Your browser is no longer supported. Please, upgrade your browser.
Quotient Limited
Index- P/E- EPS (ttm)-1.18 Insider Own1.30% Shs Outstand83.95M Perf Week0.49%
Market Cap625.36M Forward P/E- EPS next Y-0.99 Insider Trans219.91% Shs Float75.65M Perf Month-4.81%
Income-92.60M PEG- EPS next Q-0.29 Inst Own91.90% Short Float6.86% Perf Quarter34.06%
Sales41.60M P/S15.03 EPS this Y25.30% Inst Trans0.39% Short Ratio6.17 Perf Half Y-25.76%
Book/sh0.40 P/B15.35 EPS next Y5.70% ROA-39.10% Target Price- Perf Year-25.76%
Cash/sh1.60 P/C3.84 EPS next 5Y- ROE- 52W Range2.39 - 10.38 Perf YTD17.85%
Dividend- P/FCF- EPS past 5Y18.50% ROI-47.90% 52W High-40.85% Beta2.53
Dividend %- Quick Ratio4.00 Sales past 5Y12.10% Gross Margin53.90% 52W Low156.37% ATR0.35
Employees420 Current Ratio4.50 Sales Q/Q106.40% Oper. Margin- RSI (14)53.57 Volatility4.96% 5.61%
OptionableYes Debt/Eq5.34 EPS Q/Q56.20% Profit Margin- Rel Volume0.64 Prev Close5.96
ShortableYes LT Debt/Eq4.96 EarningsNov 02 BMO Payout- Avg Volume840.78K Price6.14
Recom- SMA207.54% SMA50-1.17% SMA200-5.55% Volume541,692 Change3.02%
Aug-31-17Resumed BTIG Research Buy $12
Nov-04-15Reiterated UBS Buy $25 → $26
Aug-11-15Initiated Jefferies Buy $30
Feb-04-15Reiterated UBS Buy $17 → $25
Jan-19-21 08:00AM  
Jan-12-21 09:10AM  
Jan-08-21 05:42AM  
Dec-22-20 04:05PM  
Dec-10-20 08:30AM  
Nov-30-20 04:05PM  
Nov-09-20 04:05PM  
Nov-04-20 10:05AM  
Nov-02-20 08:27AM  
Oct-29-20 12:57PM  
Oct-26-20 12:31PM  
Oct-19-20 08:48AM  
Sep-28-20 07:00AM  
Sep-19-20 07:00AM  
Sep-16-20 11:07AM  
Sep-15-20 04:05PM  
Sep-14-20 03:37PM  
Sep-10-20 08:42PM  
Sep-09-20 04:05PM  
Sep-08-20 06:15AM  
Aug-27-20 08:30AM  
Aug-04-20 09:15AM  
Aug-03-20 07:48AM  
Jul-28-20 10:49AM  
Jul-23-20 08:30AM  
Jul-20-20 10:09PM  
Jul-17-20 08:00AM  
Jul-01-20 08:00AM  
Jun-22-20 10:35AM  
Jun-11-20 10:21AM  
Jun-09-20 07:17AM  
May-26-20 04:30PM  
May-19-20 12:30PM  
May-11-20 02:00AM  
May-01-20 09:00AM  
Apr-27-20 04:05PM  
Apr-21-20 04:05PM  
Apr-06-20 08:00AM  
Mar-15-20 09:47AM  
Mar-13-20 04:30PM  
Feb-24-20 04:05PM  
Feb-14-20 08:04AM  
Feb-05-20 12:49AM  
Feb-04-20 10:08AM  
Feb-03-20 06:33AM  
Jan-30-20 07:30AM  
Jan-23-20 12:31PM  
Jan-21-20 08:00AM  
Jan-13-20 10:42AM  
Jan-10-20 04:05PM  
Jan-08-20 08:00AM  
Jan-07-20 04:05PM  
Dec-09-19 09:52AM  
Dec-05-19 04:05PM  
Nov-18-19 09:00AM  
Nov-12-19 04:05PM  
Nov-09-19 10:25PM  
Nov-06-19 10:00PM  
Nov-04-19 07:30AM  
Oct-31-19 08:00AM  
Oct-30-19 11:18AM  
Oct-28-19 10:32AM  
Oct-21-19 06:00AM  
Oct-17-19 04:51PM  
Oct-14-19 03:46PM  
Aug-14-19 01:31PM  
Aug-12-19 04:33AM  
Aug-05-19 12:23PM  
Jul-29-19 10:34AM  
Jul-22-19 08:00AM  
Jul-08-19 03:36PM  
Jul-02-19 08:00AM  
Jul-01-19 07:00AM  
Jun-20-19 12:56PM  
Jun-19-19 03:06PM  
Jun-05-19 08:00AM  
May-29-19 07:27AM  
May-28-19 10:23AM  
May-21-19 04:05PM  
May-14-19 04:05PM  
May-12-19 06:43PM  
May-01-19 04:05PM  
Apr-24-19 04:05PM  
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology and serological disease screening. Its conventional reagent products for blood grouping include antisera products that are used to identify blood group antigens; reagent red blood cells, which enable the identification of blood group antibodies; whole blood control products for use as daily quality assurance tests; and ancillary products that are used to support blood grouping. The company is also developing microarray-based SARS-CoV-2 antibody test for use on the MosaiQ platform for COVID-19. It sells its products to hospitals, donor collection agencies, independent testing laboratories, original equipment manufacturers, and blood banking operation and other diagnostics companies. Quotient Limited was founded in 2007 and is headquartered in Eysins, Switzerland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PERCEPTIVE ADVISORS LLC10% OwnerSep 15Buy4.252,911,76412,374,99716,200,818Sep 16 08:30 AM
Stackawitz JeremyChief Commercial OfficerMay 28Sale7.4111,00081,510142,926Jun 01 04:07 PM
Farrell EdwardChief Operating OfficerMay 28Sale7.4012,81194,80129,013Jun 01 04:05 PM
Buhler PeterChief Financial OfficerMar 13Buy4.0410,00040,40010,000Mar 13 07:48 PM
von Prondzynski HeinoDirectorMar 13Buy4.0030,000120,000239,922Mar 13 07:46 PM